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Abstract
Background: Partial duplications of the distal 9q have been rarely reported in literatures. The key features included
characteristic facial appearance, long fingers and toes, slight psychomotor retardation, heart murmur et al. But rare
severe congenital heart defects (CHD) such as TOF were reported to be associated with 9qter duplications.
Case presentation: A 23-year-old woman was referred for genetic counseling and prenatal diagnosis at 253/7
weeks of gestation due to her male fetus, diagnosed as Tetralogy of Fallot Syndrome (TOF) by prenatal ultrasound.
SNP (Single nucleotide polymorphism) array revealed that the male fetus had a de novo 5.47 Mb duplication at
9q34.13-qter. Meanwhile, non-invasive prenatal testing (NIPT) using low coverage whole genome massively parallel
sequencing of circulating cell-free fetal DNA (cffDNA) showed consistent results. Multiplex ligation-dependent
probe amplification (MLPA) also confirmed the duplication at 9qter.
Conclusion: In this paper, we present an Asian fetus with TOF caused by a de novo 5.47 Mb duplication at 9q34.
13-qter. Duplication of 9q34.13-qter should be considered as an etiological diagnosis in the case of TOF. Our
prenatal diagnostic findings provide important information for genetic counseling on the male fetus and future
pregnancies in this family. Chromosomal microarray analysis (CMA) remains the first-tier clinical diagnostic test for
prenatal fetus with suspicious syndromes. We also highlight the high potential application of NIPT in the screening
of sub-chromosomal rearrangement.
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Background
Partial duplications of the long arm of chromosome 9
have been rarely reported in literatures. Turleau et al. first
reported this new syndrome in 1975 [1]. The duplications
of the distal 9q are even rare, since Alldedice et al first
demonstrated the relationship between 9q34 duplications
and phenotypic abnormalities [2]. The key features in-
cluded slight psychomotor retardation, characteristic facial
appearance, fingers and toes, heart murmur et al. But rare
severe congenital heart defects (CHD) such as TOF were
reported to be associated with these duplications.
Amarillo et al. first reported the disrupted RXRA and
complex microduplication of 9q (9q+) in a patient with
TOF, suggesting that RXRA at 9q34.2 may be a critical
locus in 9q + -associated CHD [3]. Here we present a male
fetus with TOF who was found to have a de novo 5.47 Mb
duplication at 9q34.13-qter detected by SNP array, which
was confirmed by NIPT based on low coverage whole
genome massively parallel sequencing and MLPA. A lit-
erature review was performed to refine correlation of
CHD and 9q34 duplications. Our prenatal diagnostic find-
ings provide important information for genetic counseling
on the male fetus and future pregnancies in this family,
and highlight the predictive values of NIPT in the screen-
ing of sub-chromosomal rearrangement.
Case presentation
A gravida 2, para 1 woman came to our clinical genetics
center for genetic counseling at 253/7 weeks of gestation.
This is her second pregnancy. A first round prenatal ultra-
sound revealed that the male fetus (II:2) (Fig. 1a) had
multiple defects: ventricular septal defect (VSD) and
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pulmonary stenosis. Biparietal diameter was 6.76 cm
(50 ~ 95th centile) and abdominal circumference (AC)
was 23.0 cm (~95th centile). A second round prenatal
ultrasound was performed at 31 weeks of gestation,
which indicated TOF.
The mother (I:2) was 23 years old and her husband
(I:1) was 27 years old. Both of them were healthy non-
consanguineous Chinese. Their first child (II:1) was a
2.5 years old girl, born at term by vaginal delivery after
an uneventful pregnancy. Her birth weight was 3.4 kg
(50 ~ 97th centile). No significant history of anoxia was
recorded at birth. When she was 1 year old, her parents
found that her pupils of each eye were not in the same
size. After a series of examinations, she was diagnosed
as optic nerve hypoplasia, but no genetics testing was
followed up.
Amino fluid and blood samples were obtained from
the fetus and the family separately after receiving in-
formed consent. According to the genetics diagnosis and
ultrasound results, this pregnancy was subsequently ter-
minated at 32 weeks, followed by an autopsy. The male
fetus’ weight was 2052 g, height was 44.5 cm, head cir-
cumference was 30.6 cm, bust circumference was 26 cm,
and AC was 25 cm(~5th centile). Facial abnormalities:a
round face with small jaw, normal eye distance (19 mm),
flat nasal bridge, high-arched palate. Anatomical features
of heart: VSD (Fig. 1c) and displacement of the aorta to
the right side over the right ventricle (about 1/2). The
right outflow tract (pulmonary) was 0.7 cm, the left out-
flow tract (aorta) was 1.2 cm, the thickness of right ven-
tricle was 0.5 cm, left was 1.03 cm, bicuspid valve was
1.8 cm and tricuspid valve was 2.1 cm.
Materials and methods
After culturing amino fluid cells and peripheral blood
lymphocytes obtained from the fetus and the other
three family members separately, routine chromosome
G-banded (320–400 bands) karyotyping analyses were
performed on metaphase cells according to standard
protocols.
SNP array analysis: Genomic DNA was extracted from
the amino fluid cells and peripheral blood lymphocytes
by using DNA Extraction Kit (Tissue and cells) and
QIAamp DNA Blood Mini Kit (QIAGEN, Hilden,
Germany) separately. SNP array was performed using
Affymetrix CytoScan®750 K Array (Affymetrix Inc, CA,
Fig. 1 a The pedigree of this family. The red arrow indicates the proband; b G-banded karyotype of the affected fetus shows a inv(9)(p11q13)
which was inherited from his mother; c Anatomical features of heart: VSD; d MLPA result reveals that the peak height ratio of patient at 9q34.3 is
1.5, which means a duplication at this region
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USA), according to the manufacturer’s protocol. Array
results were analyzed using Chromosome Analysis Suite
(ChAS; version 2.1). All genomic coordinates were taken
from the February 2009 (hg19) human reference se-
quence (NCBI Build 37). Genes and Online Mendelian
Inheritance in Man (OMIM) references were from
RefSeq and OMIM entries, respectively.
The maternal peripheral blood was collected into
Cell-Free DNA BCT (Streck, Inc., Omaha, NE, USA)
prior to amniocentesis and centrifuged according to
the protocol. The plasma was shipped to Berry
Genomics in Beijing for DNA extraction and down-
stream low coverage whole genome massively parallel
sequencing for detection of fetal sub-chromosomal
anomalies.
The SALSA MLPA P070 kit was performed to de-
termine the DNA copy number of a single DNA se-
quence in each of 41 human subtelomeric regions.
MLPA analysis was performed following the manu-
facturer’s instructions. The products were examined
by ABI 3500dx genetic analyzer (Thermo Fisher,
USA). Quantitative data were analyzed using the
software of Coffalyser V8.0 (https://www.mlpa.com).
Results
G-banded analysis of this family showed that the fetus
inherited an inverted chromosome from his mother:
46, XY, inv(9)(p11q13), mat (Fig. 1b). The other two
showed normal karyotypes. The SNP array result of
the fetus was: arr[hg19] 9q34.13q34.3(135,550,093–
141,018,648) × 3, 16p11.2(32,564,735–33,814,547) × 1
(Fig. 2a). The proximal duplication boundary was mapped
within a 2.8-kb region between (nt. 135547269-
135550093) at 9q34.13. The elder sister had a similar dele-
tion at 16p11.2 as the fetus. No other pathogenic CNVs or
variants of uncertain significance were identified in the
parents. NIPT found a 5.6 Mb duplication in the fetus at
9q34 (Fig. 2b). MLPA analysis confirmed the duplication
at 9q34.3 (Fig. 1d).
Discussion
TOF occurs in three of every 10,000 live births. It is the
most common cause of cyanotic cardiac disease in pa-
tients beyond the neonatal age, and accounts for up to
one-tenth of all congenital cardiac lesions [4]. According
to previous study, about 10 % of CHD in children with
multiple congenital defects and/or intellectual disability
Fig. 2 The ideograph of chromosome 9 in our patient with 9q34.13-34.3 gain. a CMA (Affymetrix ChAS Browser) detects a copy number gain at
9qter. The black frame region shows: 9q34.13q34.3(135,550,093-141,018,648) x3; weighted log2 ratio (WLR) is 0.5; copy number state (CN) is 3;
allele differences (AD) (1.5, 0.5, −0.5, −1.5); smooth signal (SS) is 3; b NIPT via low coverage whole genome massively parallel sequencing of
cffDNA in maternal plasma. Z score of the red bar region is 1, which means a copy number gain of this region
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are caused by trisomies 21, 18 and 13 [5]. However, none
of these aberrations can be attributed to a single CHD
phenotype and they are associated with different CHD at
variable frequencies. With the development of CMA, ab-
errations smaller than 5 Mb can be detected and much
more submicroscopic copy number variations were
found to be associated with TOF, such as 22q11.2 dele-
tion/duplication, 1q21.1 duplication, 1q32.2 deletion,
13q13.1–13.2 deletion et al. [6–8]. Genes disrupted by
and within these CNVs thus represent excellent candi-
date genes for CHD/TOF.
In this case, the male fetus with TOF was found to
have a de novo 5.47 Mb duplication at distal 9q34 and a
1.25 Mb deletion at 16p11.2. There was no OMIM gene
within the deletion of 16p11.2. According to the data-
base of genomic variants (DGV; http://dgv.tcag.ca), this
deletion was thought to be a benign variant. 9qter dupli-
cations have been reported to be pathological for many
times since 1975 [1, 2]. Until now, there were almost 50
cases reported in DECIPHER (Database of Chromo-
somal Imbalance and Phenotype in Human using
Ensembl Resources), which overlapped with the 9qter
region we have found. A 3.0–3.4 Mb region (9q34.11-
34.13) was proposed to be critical for the presentation
of several phenotypes associated with 9q34 duplica-
tions [9, 10]. The key features included characteristic
facial appearance, long fingers and toes, slight psycho-
motor retardation, heart murmur et al.
We have compared the previously reported 9q34 du-
plications with similar sizes or within the region we de-
tected. Besides other symptoms, congenital heart defects
were not common among the 9q34 duplications (less
than 1/3 of all the previous patients). Including our case,
there were only three patients with 9qter duplications
showing TOF. The other two reports were described in
DECIPHER #284022 and by Amarillo [4]. Amarillo also
conducted a literature review to refine the correlation of
CHD and partial trisomy 9q, suggesting 9q34.2 region to
be the critical locus for 9q + -associated CHD and RXRA
to be a possible candidate gene for CHD. Another pa-
tient (DECIPHER #301594) with duplication of 9q34.13-
34.2 (inherited from his unaffected father) loci that in-
volves disruption of RXRA showed abnormality of the
ventricular septum. This also provided an evidence to
support RXRA to be a possible candidate gene for CHD.
In our case, the 5.47 Mb interval contains 92 OMIM
genes, including RXRA. However, the proximal break-
point maps to the intron 1 of GTF3C4 (*604892) at
9q34.13, which was first reported by Hsieh [11]. Until
now, there is no evidence indicating its relationship with
heart development.
According to previous reports, even the same dupli-
cations of 9q34 in the same family have different phe-
notypes [9], so phenotypic variabilities among patients
with cardiac structural defects may be attributed to in-
complete penetrance or epigenetic events. Additional
expression studies are needed to determine the role of
these genes and the region in the development of
CHD.
The existence of cffDNA in maternal circulation [12]
and the recent advent of massive parallel sequencing
technologies [13] have enabled NIPT. Peters et al. first
showed proof of concept that a fetal with a 4.2-Mb dele-
tion on chromosome 12 between bands 12p11.22 and
12p12.1 can be identified by means of noninvasive ana-
lysis of DNA in maternal plasma [14]. Liang et al. also
proved the feasibility of low-coverage massive parallel
CNV sequencing for the diagnosis of chromosome dis-
ease syndromes [15]. Helgeson et al. developed a novel
algorithm to identify fetal microdeletion events in mater-
nal plasma. They tested 175,393 samples, and 55 sub-
chromosomal deletions were reported. Their results
demonstrated high positive predictive values for nonin-
vasive testing of rare sub-chromosomal deletions [16]. In
this case, we also applied the NIPT to detect the fetal
sub-chromosomal arrangements, and we got a positive
result. This work also proved that NIPT might be ex-
panded into the detection of sub-chromosomal copy
number variations.
Conclusion
In this study, duplication of 9q34.13-qter should be con-
sidered as the etiology for this TOF. The results provide
valuable information for genetic counselors to achieve
molecular diagnosis of prenatal anomalies and make
more accurate predictions about the clinical outcomes.
CMA remains the first-tier clinical diagnostic test for
prenatal fetus with suspicious syndromes. We also high-
light the high potential application of NIPT in the
screening of sub-chromosomal rearrangement.
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